Saturday 17 October 2026
Export RVLP’s income statement to Excel — free account
RVL Pharmaceuticals PLC
RVLP Healthcare Biotechnology
RVL Pharmaceuticals PLC’s revenue for fiscal 2022 (year ended December 2022) was $49.7 million.
Follow RVLP
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '23 | Mar '23 | Dec '22 | Sep '22 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
19.16 | 32.64 | 44.54 | 59.75 |
+8 more quarters Free account |
Receivables |
1.93 | 1.88 | 3.03 | 3.28 | |
Inventory |
1.36 | 0.21 | 0.78 | 0.62 | |
Total current assets |
25.75 | 38.35 | 56.98 | 70.91 | |
Property, Plant, Equpment (Net) |
3.44 | 2.49 | 1.28 | 0.68 | |
Goodwill and Intangible Assets (Total) |
55.85 | 69.75 | 69.75 | 83.06 | |
Total non-current assets |
59.65 | 72.76 | 71.54 | 84.44 | |
Total Assets |
85.40 | 111.11 | 128.51 | 155.36 | |
Accounts Payable |
2.53 | 2.63 | 2.41 | 7.00 | |
Accrued Expenses |
7.86 | 9.27 | 15.40 | 13.95 | |
Current Part of Debt |
57.75 | 4.15 | 1.43 | 0.52 | |
Current Part of Capital Lease |
0.01 | 0.01 | 0.01 | 0.01 | |
Current Part of Taxes to Pay |
0.05 | 0.04 | 0.04 | 0.01 | |
Total current liabilities |
68.39 | 16.41 | 19.72 | 21.48 | |
Long Term Debt (Total) |
0.01 | 53.05 | 55.52 | 55.92 | |
Long Term Tax Liability (Deferred) |
0.03 | 0.07 | 0.06 | 0.19 | |
Non-current Liabilities (Other) |
0.47 | 1.35 | 2.02 | 9.00 | |
Total non-current liabilities |
0.69 | 54.70 | 57.69 | 65.33 | |
Total liabilities |
69.08 | 71.11 | 77.42 | 86.81 | |
Additional Paid In Capital |
620.06 | 619.84 | 619.32 | 618.46 | |
Common Stock (Net) |
0.99 | 0.99 | 0.99 | 0.99 | |
Retained Earnings |
(604.72) | (580.83) | (569.22) | (550.90) | |
Common Equity (Total) |
16.33 | 40.00 | 51.09 | 68.55 | |
Shareholders Equity (Total) |
16.33 | 40.00 | 51.09 | 68.55 | |
Shareholders Equity and Liabilities (Total) |
85.40 | 111.11 | 128.51 | 155.36 | |
Shares (Common) |
99.39 | 99.35 | 99.16 | 99.15 | |
Shareholders Equity (Tangible) |
(39.52) | (29.75) | (18.65) | (14.51) | |
Net Debt |
38.60 | 24.56 | 12.41 | (3.31) | |
Total Debt |
57.76 | 57.20 | 56.95 | 56.44 |
In millions of $ except per-share values · columns are period end dates